Suppr超能文献

病例报告:晚期上皮性卵巢癌的微创初次肿瘤细胞减灭术

Case report: Minimally invasive primary debulking surgery for advanced stage epithelial ovarian cancer.

作者信息

Wolf Jennifer, Goncalves Nicole, Alagkiozidis Ioannis

机构信息

State University of New York (SUNY) Downstate Health Sciences University, Department of Obstetrics & Gynecology, Brooklyn, NY, United States.

Maimonides Medical Center, Department of Obstetrics & Gynecology, Brooklyn, NY, United States.

出版信息

Front Oncol. 2024 Feb 2;14:1302724. doi: 10.3389/fonc.2024.1302724. eCollection 2024.

Abstract

The surgical management of advanced ovarian cancer has historically emphasized an open technique, but advances in minimally invasive surgery (MIS) have led to its increasing use in ovarian cancer. Most research has focused on the utility of MIS in the interval debulking setting. Here, we present a case of a 38-year-old patient with incidentally diagnosed advanced stage ovarian cancer. We describe the robotic surgery techniques used to achieve complete primary cytoreduction, including resection of disease on the diaphragm. The patient has completed standard adjuvant chemotherapy and maintenance treatment and remains without evidence of disease for more than 2 years. This case details the techniques utilized to achieve complete cytoreduction including trocar placement, robotic instrument preference, and rotation of the robotic boom. This patient has had successful perioperative and oncologic outcomes, and her case highlights the role for minimally invasive primary debulking surgery for select patients with advanced ovarian cancer.

摘要

从历史上看,晚期卵巢癌的外科治疗一直强调开放手术技术,但微创外科手术(MIS)的进展已使其在卵巢癌中的应用越来越多。大多数研究都集中在MIS在中间减瘤手术中的效用。在此,我们介绍一例38岁偶然诊断为晚期卵巢癌的患者。我们描述了用于实现完全初次细胞减灭术的机器人手术技术,包括膈肌上病灶的切除。该患者已完成标准辅助化疗和维持治疗,且超过2年无疾病证据。本病例详细介绍了实现完全细胞减灭术所采用的技术,包括套管针放置、机器人器械选择以及机器人机械臂的旋转。该患者围手术期和肿瘤学结局均成功,她的病例凸显了微创初次减瘤手术对部分晚期卵巢癌患者的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c79f/10870411/74b978d6347d/fonc-14-1302724-g001.jpg

相似文献

1
Case report: Minimally invasive primary debulking surgery for advanced stage epithelial ovarian cancer.
Front Oncol. 2024 Feb 2;14:1302724. doi: 10.3389/fonc.2024.1302724. eCollection 2024.
2
Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
Int J Gynecol Cancer. 2019 Nov;29(9):1341-1347. doi: 10.1136/ijgc-2019-000413. Epub 2019 Oct 9.
5
Laparoscopic cytoreduction After Neoadjuvant ChEmotherapy (LANCE).
Int J Gynecol Cancer. 2020 Sep;30(9):1450-1454. doi: 10.1136/ijgc-2020-001584. Epub 2020 Jul 20.
6
[Epithelial ovarian cancers and minimally invasive cytoreductive surgery after neoadjuvant chemotherapy: A systematic review].
Gynecol Obstet Fertil Senol. 2021 Oct;49(10):736-743. doi: 10.1016/j.gofs.2021.02.006. Epub 2021 Feb 23.
7
Does MIS Play a Role in the Treatment of Advanced Ovarian Cancer?
Cancers (Basel). 2022 Jul 22;14(15):3579. doi: 10.3390/cancers14153579.
8
Robotic surgery in ovarian cancer.
Best Pract Res Clin Obstet Gynaecol. 2023 Aug;90:102391. doi: 10.1016/j.bpobgyn.2023.102391. Epub 2023 Jul 12.
9
Nomogram to predict feasibility of minimally invasive interval debulking surgery in advanced ovarian cancer.
Int J Gynecol Cancer. 2022 Apr 4;32(4):532-539. doi: 10.1136/ijgc-2021-002908.

引用本文的文献

1
Extragonadal immature teratoma of the uterus.
Gynecol Oncol Rep. 2025 Feb 22;58:101707. doi: 10.1016/j.gore.2025.101707. eCollection 2025 Apr.

本文引用的文献

2
Minimally invasive interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapy.
Gynecol Oncol. 2023 May;172:130-137. doi: 10.1016/j.ygyno.2023.01.017. Epub 2023 Mar 26.
3
Minimally invasive surgery versus open surgery in high-risk histologic endometrial cancer patients: A meta-analysis.
Gynecol Oncol. 2022 Aug;166(2):236-244. doi: 10.1016/j.ygyno.2022.06.004. Epub 2022 Jun 17.
6
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).
Int J Gynecol Cancer. 2020 Nov;30(11):1657-1664. doi: 10.1136/ijgc-2020-001640. Epub 2020 Oct 7.
7
Laparotomy minimally invasive surgery for ovarian cancer recurrence: a systematic review.
Gland Surg. 2020 Aug;9(4):1130-1139. doi: 10.21037/gs-20-353.
8
The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer.
Ann Surg Oncol. 2021 Jan;28(1):244-251. doi: 10.1245/s10434-020-08649-6. Epub 2020 May 29.
9
Lymphadenectomy in Ovarian Cancer: Is It Still Justified?
Curr Oncol Rep. 2020 Feb 8;22(3):22. doi: 10.1007/s11912-020-0883-2.
10
Robotic Resection of Diaphragm Metastases in Ovarian Cancer: Technical Aspects.
J Minim Invasive Gynecol. 2020 Sep-Oct;27(6):1417-1422. doi: 10.1016/j.jmig.2019.12.018. Epub 2020 Jan 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验